These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25236981)

  • 21. Prognostic impact of pattern-based grading system by the new IASLC/ATS/ERS classification in Asian patients with stage I lung adenocarcinoma.
    Zhao ZR; Xi SY; Li W; Situ DR; Chen KM; Yang H; Su XD; Lin YB; Long H
    Lung Cancer; 2015 Dec; 90(3):604-9. PubMed ID: 26547801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between epidermal growth factor receptor mutation and histologic subtypes or characteristics of computed tomography findings in patients with resected pulmonary adenocarcinoma.
    Wang D; Yan N; Yang X; Ge Y; Xu D; Shao G; Peng Z
    J Cancer Res Ther; 2018 Jan; 14(1):240-244. PubMed ID: 29516992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
    Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
    Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
    Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification in stage IB lung adenocarcinoma.
    Xu CH; Wang W; Wei Y; Hu HD; Zou J; Yan J; Yu LK; Yang RS; Wang Y
    Eur J Surg Oncol; 2015 Oct; 41(10):1430-6. PubMed ID: 26123994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of postoperative adjuvant therapy on EGFR-mutated stage IA lung adenocarcinoma with micropapillary pathological subtypes.
    Cheng R; Hao Z; Qiu L; Zheng X; Huang S; Xian J; Huang H; Li J; Zhang Z; Ye K; Wu W; Zhang Y; Liu J
    World J Surg Oncol; 2024 Sep; 22(1):235. PubMed ID: 39232762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between
    Bu L; Tu N; Wang K; Zhou Y; Xie X; Han X; Lin H; Feng H
    Korean J Radiol; 2022 Jan; 23(1):112-123. PubMed ID: 34983098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma.
    Yeh YC; Kadota K; Nitadori J; Sima CS; Rizk NP; Jones DR; Travis WD; Adusumilli PS
    Eur J Cardiothorac Surg; 2016 Jan; 49(1):e9-e15. PubMed ID: 26377636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Histopathological Feature of EGFR-Mutated Lung Adenocarcinomas with Highly Malignant Potential - An Implication of Micropapillary Element.
    Matsumura M; Okudela K; Kojima Y; Umeda S; Tateishi Y; Sekine A; Arai H; Woo T; Tajiri M; Ohashi K
    PLoS One; 2016; 11(11):e0166795. PubMed ID: 27861549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiogenomic correlation in lung adenocarcinoma with epidermal growth factor receptor mutations: Imaging features and histological subtypes.
    Hong SJ; Kim TJ; Choi YW; Park JS; Chung JH; Lee KW
    Eur Radiol; 2016 Oct; 26(10):3660-8. PubMed ID: 26787602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between the histological subtype of lung adenocarcinoma, EGFR/KRAS mutation status and the ALK rearrangement according to the novel IASLC/ATS/ERS classification.
    Dong YJ; Cai YR; Zhou LJ; Su D; Mu J; Chen XJ; Zhang LI
    Oncol Lett; 2016 Apr; 11(4):2552-2558. PubMed ID: 27073516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Why do pathological stage IA lung adenocarcinomas vary from prognosis?: a clinicopathologic study of 176 patients with pathological stage IA lung adenocarcinoma based on the IASLC/ATS/ERS classification.
    Zhang J; Wu J; Tan Q; Zhu L; Gao W
    J Thorac Oncol; 2013 Sep; 8(9):1196-202. PubMed ID: 23945388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is MPP a good prognostic factor in stage III lung adenocarcinoma with EGFR exon 19 mutation?
    Zhang T; Wang J; Su Y; Chen X; Yan Q; Li Q; Sun L; Wang Y; Er P; Pang Q; Wang P
    Oncotarget; 2017 Jun; 8(25):40594-40605. PubMed ID: 28380449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.
    Takahashi M; Shigematsu Y; Ohta M; Tokumasu H; Matsukura T; Hirai T
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):54-9. PubMed ID: 24131786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of GLUT1 and Ki-67 expression on early‑stage lung adenocarcinoma diagnosed according to a new international multidisciplinary classification.
    Maki Y; Soh J; Ichimura K; Shien K; Furukawa M; Muraoka T; Tanaka N; Ueno T; Yamamoto H; Asano H; Tsukuda K; Toyooka S; Miyoshi S
    Oncol Rep; 2013 Jan; 29(1):133-40. PubMed ID: 23076555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of stage I lung adenocarcinoma: A retrospective study based on analysis of 110 Chinese patients.
    Zhao X; Zhang Y; Qian K; Zhao L; Wang W; Teng LH
    Thorac Cancer; 2017 Nov; 8(6):565-571. PubMed ID: 28834269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relevance of the novel IASLC/ATS/ERS classification of lung adenocarcinoma in advanced disease.
    Campos-Parra AD; Avilés A; Contreras-Reyes S; Rojas-Marín CE; Sánchez-Reyes R; Borbolla-Escoboza RJ; Arrieta O
    Eur Respir J; 2014 May; 43(5):1439-47. PubMed ID: 24435003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comprehensive investigation of molecular features and prognosis of lung adenocarcinoma with micropapillary component.
    Zhang Y; Wang R; Cai D; Li Y; Pan Y; Hu H; Wang L; Li H; Ye T; Luo X; Zhang Y; Li B; Shen L; Sun Y; Chen H
    J Thorac Oncol; 2014 Dec; 9(12):1772-8. PubMed ID: 25226429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival.
    Hung JJ; Yeh YC; Jeng WJ; Wu KJ; Huang BS; Wu YC; Chou TY; Hsu WH
    J Clin Oncol; 2014 Aug; 32(22):2357-64. PubMed ID: 24799473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiological study of HER-2 mutations among EGFR wild-type lung adenocarcinoma patients in China.
    Li X; Zhao C; Su C; Ren S; Chen X; Zhou C
    BMC Cancer; 2016 Oct; 16(1):828. PubMed ID: 27793199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.